Please activate JavaScript!
Please install Adobe Flash Player, click here for download
ePaper created 2017-01-19, 09:12:17 | version 1.38.0
INDUSTRY Implant Tribune U.S. Edition | September 2016 B8 AD Osteogenics secures North American distribution of Resorba dental sutures By Osteogenics Staff O steogenics Biomedical, a lead- er in the development of in- novative dental bone grafting products, recently announced the acquisition of exclusive North Ameri- can distribution rights for the premium German dental suture brand, Resorba.® While most sutures in dentistry are simply repositioned from medicine, Re- sorba, a major suture manufacturer in Germany since 1931, created a division exclusively for dentistry. Resorba com- bines unique materials with specialty dental needles to create products better suited for dental surgery. Among its unique product offering is its best-selling dental suture, Glycolon™, an absorbable suture with a monoila- ment construction comprised of poly- glycolic acid (PGA) and polycaprolac- tone (PCL). The monoilament structure provides excellent handling properties, does not wick bacteria and allows for atraumatic passage through tissue. Gly- colon maintains 50 percent of its tensile strength for 11 to 13 days. Resorba dental suture needles are manufactured from premium tempered 300-series stainless steel. Select conigu- rations are also available with a black needle that provides increased contrast in the mouth for enhanced visualization. “Following the success of our own Cytoplast™ PTFE suture line, expan- sion of our suture portfolio was a long- term goal,” said Osteogenics president, Shane Shuttlesworth. “Resorba’s focus on unique, premium products designed for dentistry its perfectly within our prod- uct portfolio philosophy.” For more information on the com- plete line of Resorba dental sutures, visit osteogenics.com/resorbasutures, or con- tact a customer service specialist at (888) 796-1923. About Osteogenics Biomedical Headquartered in Lubbock, Texas, Osteogenics Biomedical is a leader in the development of innovative dental bone grafting products serving periodontists, oral and maxillofacial surgeons and cli- nicians throughout the world who are involved with regenerative and implant dentistry. Osteogenics offers a complete line of bone grafting products includ- ing enCore® Combination and Mineral- ized Allografts, Cytoplast PTFE mem- branes, Cytoplast collagen membranes, Vitala™ porcine pericardium collagen membranes, Cytoplast PTFE suture, NovaBone® bone graft putty, the Pro-ix™ Precision Fixation System and Resorba® dental sutures. Photo/Provided by Osteogenics ‘Resorba’s focus on unique, premium products designed for dentistry its perfectly within our product portfolio philosophy.’